New & Improved!

Submit a New & Noteworthy
April 2019
Bordetella Test
By: DiaSorin

DiaSorin Molecular has received FDA clearance for its new Simplexa Bordetella Direct test. This CLIA moderate-complexity assay is designed for use on the LIAISON MDX to quickly provide qualitative detection and differentiation of both Bordetella pertussis and Bordetella parapertussis in nasopharyngeal swabs. The assay is performed directly from NPS samples without extraction and provides results in approximately one hour. Pertussis can lead to more severe symptoms such as hypoxia, permanent brain damage, or death, particularly in infants.

DiaSorin

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register:

    As of May 24, 2018, www.medlabmag.com's Terms of Use and Privacy Policy have been updated.
    You can review the Terms of Use HERE and the Privacy Policy HERE.
    By continuing to use www.medlabmag.com, you are agreeing to these changes.